Short-course systemic corticosteroids in asthma : striking the balance between efficacy and safety

Price, DavidCastro, MarioBourdin, ArnaudFucile, SebastianAltman, Pablo2020-05-042020-05-042020Price, D, Castro, M, Bourdin, A, Fucile, S & Altman, P 2020, 'Short-course systemic corticosteroids in asthma : striking the balance between efficacy and safety', European respiratory review : an official journal of the European Respiratory Society, vol. 29, no. 155, 190151. https://doi.org/10.1183/16000617.0151-20190905-9180https://hdl.handle.net/2164/14232The authors thank Gillian Lavelle and Claire Twomey (Novartis Product Lifecycle Services, Dublin, Ireland) for providing scientific writing support for this article, which was funded by Novartis Pharma AG (Basel, Switzerland) in accordance with Good Publication Practice (GPP3) guidelines (www.ismpp.org/gpp3).8315398engSDG 3 - Good Health and Well-beingAdrenal Cortex Hormones/adverse effectsAnti-Asthmatic Agents/adverse effectsAsthma/drug therapyHumansMorbidityRisk FactorsTreatment OutcomeGLUCOCORTICOIDSBONE-MINERAL DENSITYCHILDRENIMPACTORAL CORTICOSTEROIDSOUTCOMESAPPROPRIATE USER MedicineRShort-course systemic corticosteroids in asthma : striking the balance between efficacy and safetyJournal item10.1183/16000617.0151-2019http://www.scopus.com/inward/record.url?scp=85083041581&partnerID=8YFLogxK29155